APA (7th ed.) Citation

RG, A., P, G., L, N., AJ, S., K, N., J, T., . . . JA, C. (2021). Combined OX40 Agonist and PD-1 Inhibitor Immunotherapy Improves the Efficacy of Vascular Targeted Photodynamic Therapy in a Urothelial Tumor Model. Molecules (Basel, Switzerland), 26(12), . https://doi.org/10.3390/molecules26123744

Chicago Style (17th ed.) Citation

RG, Alvim, et al. "Combined OX40 Agonist and PD-1 Inhibitor Immunotherapy Improves the Efficacy of Vascular Targeted Photodynamic Therapy in a Urothelial Tumor Model." Molecules (Basel, Switzerland) 26, no. 12 (2021). https://doi.org/10.3390/molecules26123744.

MLA (9th ed.) Citation

RG, Alvim, et al. "Combined OX40 Agonist and PD-1 Inhibitor Immunotherapy Improves the Efficacy of Vascular Targeted Photodynamic Therapy in a Urothelial Tumor Model." Molecules (Basel, Switzerland), vol. 26, no. 12, 2021, https://doi.org/10.3390/molecules26123744.